Items where authors include "Levin, J."

Article

Rudolph, J. orcid.org/0000-0002-4849-8034, Rueckel, J., Döpfert, J. et al. (35 more authors) (2024) Artificial intelligence–based rapid brain volumetry substantially improves differential diagnosis in dementia. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 16 (4). e70037. ISSN 2352-8729

Brendel, M., Parvizi, T., Gnörich, J. et al. (23 more authors) (2024) Aβ status assessment in a hypothetical scenario prior to treatment with disease‐modifying therapies: evidence from 10‐year real‐world experience at university memory clinics. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 16 (4). e70031. ISSN 2352-8729

Dilcher, R. orcid.org/0000-0002-1307-6747, Wall, S., Groß, M. et al. (27 more authors) (2024) Combining cerebrospinal fluid and PI‐2620 tau‐PET for biomarker‐based stratification of Alzheimer's disease and 4R‐tauopathies. Alzheimer's & Dementia, 20 (10). pp. 6896-6909. ISSN 1552-5260

Zatcepin, A. orcid.org/0000-0002-0224-088X, Gnörich, J., Rauchmann, B.-S. et al. (41 more authors) (2024) Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease. Molecular Neurodegeneration, 19. 64.

Malpetti, M. orcid.org/0000-0001-8923-9656, Roemer, S.N., Harris, S. et al. (20 more authors) (2024) Neuroinflammation parallels 18F‐PI‐2620 positron emission tomography patterns in primary 4‐repeat tauopathies. Movement Disorders, 39 (9). pp. 1480-1492. ISSN 0885-3185

Chatterjee, M., Özdemir, S., Fritz, C. et al. (82 more authors) (2024) Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nature Medicine, 30. pp. 1771-1783. ISSN 1078-8956

Ye, L., Greten, S. orcid.org/0000-0003-0638-8571, Wegner, F. et al. (95 more authors) (2024) The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis. Journal of Neurology, 271. pp. 2639-2648. ISSN 0340-5354

Stockbauer, A., Beyer, L., Huber, M. et al. (39 more authors) (2024) Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. European Journal of Nuclear Medicine and Molecular Imaging, 51. pp. 1023-1034. ISSN 1619-7070

Greten, S. orcid.org/0000-0003-0638-8571, Wegner, F., Jensen, I. et al. (64 more authors) (2024) The comorbidity and co-medication profile of patients with progressive supranuclear palsy. Journal of Neurology, 271 (2). pp. 782-793. ISSN 0340-5354

Biechele, G., Rauchmann, B.-S., Janowitz, D. et al. (30 more authors) (2024) Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease. Journal of Neuroinflammation, 21 (1). 30. ISSN 1742-2094

Finze, A., Biechele, G., Rauchmann, B.-S. et al. (41 more authors) (2023) Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Molecular Psychiatry, 28 (10). pp. 4438-4450. ISSN 1359-4184

Völter, F., Beyer, L., Eckenweber, F. et al. (17 more authors) (2023) Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings. European Journal of Nuclear Medicine and Molecular Imaging, 50 (5). pp. 1384-1394. ISSN 1619-7070

Rullmann, M., Brendel, M., Schroeter, M.L. et al. (11 more authors) (2022) Multicenter 18F-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer’s disease. Biomolecules, 12 (3). 458. ISSN 2218-273X

Schuster, S., Beyer, L. orcid.org/0000-0002-7358-4495, Palleis, C. et al. (21 more authors) (2022) Impact of partial volume correction on [18F]GE-180 PET quantification in subcortical brain regions of patients with corticobasal syndrome. Brain Sciences, 12 (2). 204. ISSN 2076-3425